Edition:
United Kingdom

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

205.37USD
14 Dec 2018
Change (% chg)

$-6.58 (-3.10%)
Prev Close
$211.95
Open
$210.84
Day's High
$211.44
Day's Low
$202.74
Volume
841,760
Avg. Vol
522,814
52-wk High
$227.12
52-wk Low
$163.02

Select another date:

Thu, Nov 1 2018

Photo

Cigna boosts 2018 forecast after third quarter earnings beat

U.S. health insurer Cigna Corp , which is in the process of acquiring Express Scripts Holding Co , significantly bumped up its 2018 adjusted profit forecast, and its shares rose more than 3 percent on Thursday.

UPDATE 3-Cigna boosts 2018 forecast after third quarter earnings beat

* Shares up 3.1 percent at $220.26 (Adds details from conference call, analyst quote, shares)

Cigna's third-quarter profit rises driven by lower medical costs

Nov 1 Cigna Corp on Thursday reported a higher third quarter profit, helped by lower medical costs in its government healthcare plans.

Cigna deal gets antitrust nod, positive sign for CVS-Aetna

Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing them to proceed with a combination they say will lead to lower costs by better coordinating pharmacy and medical benefits.

Cigna-Express scripts deal gets anti-trust approval

Sept 17 - Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing a combination the companies say will lead to lower costs by better coordinating pharmacy and medical benefits.

Deals of the day-Mergers and acquisitions

Aug 24 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Cigna, Express Scripts shareholders approve $52 billion deal

Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co , although the deal still needs clearance from antitrust authorities.

UPDATE 2-Cigna, Express Scripts shareholders approve $52 bln deal

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, although the deal still needs clearance from antitrust authorities.

Cigna shareholders approve $52 bln Express Scripts acquisition

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, but the deal still needs antitrust approval to move forward.

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Select another date: